BAP1 and cancer: Interestingly, BAP1 and PSMD13 genetic alterations do not co-occur in any of the samples reported in these studies (Figure S2), suggesting that the presence of mutations in both genes compromise cell viability, not only in MPM, but also in BAP1-TPDS-related cancer types.